CB Insights
Technology Market Intelligence
Technology Market Intelligence
Public list: BIO 2016 (619) Pharma Startups (6570) Rare Diseases (230)
Ultragenyx Pharmaceutical is a developmental stage biotechnology company committed to bringing life-enhancing therapeutics for patients with rare and ultra-rare genetic diseases, also known as orphan diseases, to market. The company focuses on metabo...Show all
Company (IPO / Went public)
Phone: 415-483-8800
60 Leveroni Court
Novato, 94949
California, United States
| Total Funding | Date of Last Funding | |
|---|---|---|
| Ultragenyx Pharmaceutical | $135M | Jan 31, 2014 |
| Alexza Pharmaceuticals | $163.4M | May 10, 2016 |
| Agios Pharmaceuticals | $376.3M | Jul 24, 2013 |
| See all 5 competitors | ||
| Per Week | Per Month | Per 6 Months | Per Year | |
|---|---|---|---|---|
| Rank | Login to see details | |||
| Page Views Per Million | Login to see details | |||
| Page Views Per User | Login to see details | |||
| Reach Per Million | Login to see details | |||
| Title | Application Date | Patent Date | Status (Patent / Application) |
|---|---|---|---|
| Sialic acid analogs | Sep 16, 2019 | Jan 12, 2021 | Patent |
| Effective and efficient control of serum phosphate for optimal bone formation | May 29, 2015 | May 05, 2020 | Patent |
| Sialic acid analogs | Jul 31, 2018 | Oct 29, 2019 | Patent |
| Crystal forms of sialic acid or salt or solvate thereof | Sep 14, 2016 | Aug 20, 2019 | Patent |
| Sialic acid analogs | Nov 18, 2015 | Sep 04, 2018 | Patent |
